Clinical Trials Browser

Recruiting × Alzheimer Disease × 90 days × Clear all

NCT06745583 2026-06-03

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Phase 2 Recruiting

15 enrolled

Lymphoid

Neuroinflammatory Diseases, Alzheimer Disease, Lymphoma, Follicular, Neurodegenerative Diseases, Cognitive Dysfunction

NCT07102212 2026-05-18

FOCUS

Phase NA Recruiting

120 enrolled

BreastDermatologicGenitourinaryPlasma cellThoracic

Alzheimer Disease, Anxiety Disorders, Breast Neoplasms, Depression, Fatigue, Lung Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

NCT07532590 2026-05-11

Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content (PancreasPlus).

Phase NA Recruiting

185 enrolled

Agnosia, Alzheimer Disease

NCT06362707 2026-05-04

FEAD

Phase 2 Recruiting

200 enrolled

Lymphoid

Alzheimer Disease, Lymphoma, Follicular, Cognitive Dysfunction

NCT06352710 2026-03-19

Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment

Recruiting

400 enrolled

CNS

Alzheimer Disease, Aneurysm, Brain Neoplasms

NCT07332377 2026-03-18

PsyMINT

Phase NA Recruiting

25 enrolled

Agnosia, Alzheimer Disease, Pain